Tg Therapeutics (TGTX) Stock Price, Quote & News

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's de...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 554 4484

Fax: 212 554 4531

Website: www.tgtherapeutics.com

Address:

3020 Carrington Mill Blvd., Suite 475, Morrisville, United States

neilinva Nov. 23 at 12:40 AM

$TGTX A Question for the board — If a company wants to pursue a TGTX purchase — do they get to see the internal data on subQ and /or the MG test. Or are they restricted to only publicly available info. How much is TGTX legally allowed to provide —- that is unavailable to the rest of us. Comments welcome.

1 · Reply

Chartist0_0 Nov. 22 at 11:05 PM

$TGTX sideways for 5 years. Up 1.50$ Friday and people think it’s a new bull market

0 · Reply

AB_Research Nov. 22 at 10:36 PM

$TGTX If you disagree with Chartist, you will get blocked. Biggest coward on the internet.

1 · Reply

Bobes Nov. 22 at 9:58 PM

$TGTX so much fake news and misdirection. Its tiring. Fact is the company beats and raises every q. Fact is btks have toxicity issues and its two pills a day for the rest of your life. Btks have shown not to beat cd20s. Fact is MW hasnt sold a share or diluted. Fact is they are becoming the cd20 of choice. Fact is 95% of 2025 revenue will comeback next year. Fact is subq has a high probability of working since subq ocrevus worked and so does K. Is that enough? Stock price and company performance are disconnected. Look at the headlines... slowing growing.... what they beat and raised... what they just said they are gaining traction. Low iq investors are selling

3 · Reply

Chartist0_0 Nov. 22 at 9:25 PM

$TGTX $RIGL has a fraction of the market cap and sales, yet somehow much better earnings projections for 2026. RIGL might just be a monster. TGTX might tread water without a buyout.

3 · Reply

ChartistMoM Nov. 22 at 4:02 PM

$TGTX Step back. Look and see. My son the Shartist works for the put buyer. Tell him it is so.

1 · Reply

Rutgers Nov. 22 at 3:42 PM

$TGTX Hey Sharitist, please share thoughts on direction now….haven’t heard from you last couple days of rally?

3 · Reply

TGTX2025 Nov. 22 at 2:53 PM

$TGTX sep 13 SP was roughly the same as it is now but PE ratio was 79.45. Idk if market being closed affects this but now we’re @ 10.96. I’m not great with stocks but I know 10.96 PE ratio is better than 79.45 just curious what anyone else thinks.. this is good right? 😃

1 · Reply

MoneyGroupLLC Nov. 22 at 8:21 AM

Enter: $TGTX Calls Strike Price: $32 Expiry Date: DEC 19 2025 Buy in Price: $2.00 - $2.15 Sell Price: $4.02 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

LiquidThetaOptions Nov. 22 at 5:38 AM

💎 LiquidTheta® Live Actionable Trade Asset: $TGTX Contracts: $TGTX January 15, 2027 $32 Calls Scale in: $7.56- $9.24 Scale out: $29.40-$50.40 Profit Potential : 407% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

TG Therapeutics: Concerns About Slowing Growth And New Competition

Nov 17, 2025, 5:49 PM EST - 5 days ago

TG Therapeutics: Positives From Q3'25 Earnings, But Competitors Progressing

Nov 3, 2025, 3:48 PM EST - 19 days ago

TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows

Nov 3, 2025, 11:56 AM EST - 19 days ago

TG Therapeutics, Inc. (TGTX) Q3 2025 Earnings Call Transcript

Oct 31, 2025, 7:30 AM EDT - 22 days ago

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update

Oct 28, 2025, 7:30 AM EDT - 25 days ago

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

Sep 24, 2025, 9:10 AM EDT - 2 months ago

New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment

Sep 10, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

Sep 8, 2025, 7:30 AM EDT - 2 months ago

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment

Sep 4, 2025, 7:57 AM EDT - 2 months ago

TG Therapeutics, Inc. (TGTX) Presents at Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program

Aug 28, 2025, 8:00 AM EDT - 3 months ago

TG Therapeutics to Participate in the Cantor Global Healthcare Conference

Aug 4, 2025, 10:19 AM EDT - 3 months ago

TG Therapeutics, Inc. (TGTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:00 AM EDT - 3 months ago

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

Jul 30, 2025, 7:30 AM EDT - 4 months ago

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

Jun 25, 2025, 4:05 PM EDT - 5 months ago

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel

Jun 9, 2025, 4:51 PM EDT - 5 months ago

Evercore ISI's Julian Emanuel says now is the time to buy small-caps

CNS LEU RMBS SFM

Jun 6, 2025, 7:30 AM EDT - 6 months ago

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 6:00 AM EDT - 6 months ago

TG Therapeutics: Estimates Could Soon Be Raised Again

May 27, 2025, 7:30 AM EDT - 6 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

May 5, 2025, 4:37 PM EDT - 7 months ago

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

May 5, 2025, 1:30 PM EDT - 7 months ago

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges

May 5, 2025, 10:55 AM EDT - 7 months ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 7:00 AM EDT - 7 months ago

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

Apr 30, 2025, 7:30 AM EDT - 7 months ago

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

Apr 10, 2025, 7:30 AM EDT - 8 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Apr 7, 2025, 7:30 AM EDT - 8 months ago

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Mar 21, 2025, 11:50 AM EDT - 8 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 15, 2025, 8:42 AM EDT - 9 months ago

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel

Mar 14, 2025, 2:04 PM EDT - 9 months ago

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials

Mar 12, 2025, 4:11 PM EDT - 9 months ago

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter

Mar 7, 2025, 7:30 AM EST - 9 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Mar 4, 2025, 7:03 AM EST - 9 months ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT GILD PRVA TKO

Mar 3, 2025, 3:59 PM EST - 9 months ago

TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 11:55 AM EST - 9 months ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:30 AM EST - 9 months ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Feb 26, 2025, 7:30 AM EST - 9 months ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 18, 2025, 10:20 AM EST - 9 months ago

20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset'

ARWR AUB CRK CYTK EXE KRYS MARA

Jan 23, 2025, 2:48 PM EST - 10 months ago

TG Therapeutics: Entering 2025 With Increased Investor Expectations

Jan 21, 2025, 2:17 AM EST - 10 months ago

TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 13, 2025, 11:38 PM EST - 11 months ago

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst

Jan 9, 2025, 7:30 AM EST - 11 months ago

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 7:36 AM EST - 1 year ago

20 stocks likely to lag the S&P 500 over the next year — for this one reason

CELH CENX CNXC CRSR CXM FLG GEO

Nov 29, 2024, 8:00 AM EST - 1 year ago

TG Therapeutics to Participate in the Evercore HealthCONx Conference

Nov 21, 2024, 6:00 AM EST - 1 year ago

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 5, 2024, 1:50 PM EST - 1 year ago

TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates

Nov 4, 2024, 8:27 PM EST - 1 year ago

TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell

Nov 4, 2024, 11:16 AM EST - 1 year ago

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 9:00 AM EST - 1 year ago

FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics

neilinva Nov. 23 at 12:40 AM

1 · Reply

Chartist0_0 Nov. 22 at 11:05 PM

$TGTX sideways for 5 years. Up 1.50$ Friday and people think it’s a new bull market

0 · Reply

AB_Research Nov. 22 at 10:36 PM

$TGTX If you disagree with Chartist, you will get blocked. Biggest coward on the internet.

1 · Reply

Bobes Nov. 22 at 9:58 PM

3 · Reply

Chartist0_0 Nov. 22 at 9:25 PM

$TGTX $RIGL has a fraction of the market cap and sales, yet somehow much better earnings projections for 2026. RIGL might just be a monster. TGTX might tread water without a buyout.

3 · Reply

ChartistMoM Nov. 22 at 4:02 PM

$TGTX Step back. Look and see. My son the Shartist works for the put buyer. Tell him it is so.

1 · Reply

Rutgers Nov. 22 at 3:42 PM

$TGTX Hey Sharitist, please share thoughts on direction now….haven’t heard from you last couple days of rally?

3 · Reply

TGTX2025 Nov. 22 at 2:53 PM

1 · Reply

MoneyGroupLLC Nov. 22 at 8:21 AM

0 · Reply

LiquidThetaOptions Nov. 22 at 5:38 AM

0 · Reply

NiceBuzz Nov. 22 at 5:34 AM

$TGTX @Pennzwoods I have 145kish now and will not sell a share until the pink bird does. Bottom seems to be around 30 with a lot of upside.

0 · Reply

StockDreamin Nov. 22 at 12:42 AM

$TGTX wow! She held after hours!

0 · Reply

ern1in Nov. 21 at 11:32 PM

$TGTX YIKES !!!!! Never bought bitcoin, never will !

1 · Reply

Lions1_83 Nov. 21 at 11:09 PM

$TGTX Nice way to end the week . Now let's have a little follow through on Monday . Have a good weekend all 💰

0 · Reply

HedgeAlerts Nov. 21 at 10:43 PM

Hedge Alert Live - Protect Your Portfolio Contract: $TGTX $31.00 Put · NOV 28, 2025 Exp Entry Price: $1.20 - $1.40 Exit Price Target: $2.72 Profit Margin: +94% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

Iightning Nov. 21 at 10:28 PM

1ightning® Options Trade Alert (Actionable) | Buy $TGTX Dec 19 $32 Call | Enter: $1.82 Exit: $3.29 | Profit: 80.61% ROI | https://1ightning.com

0 · Reply

neilinva Nov. 21 at 9:58 PM

$TGTX With next week - being Turkey week — looking for TGTX to go up. There is a lot of weakness in the market , but TGTX is poised for higher prices. It’s been a long wait for this turn around. GLTA.

0 · Reply

Kobe2324 Nov. 21 at 9:05 PM

$TGTX I could see us slowly move upward into J.P. Morgan.

1 · Reply

jmartin795 Nov. 21 at 9:01 PM

$TGTX 1 million shares of dark pool posted.

0 · Reply

jmartin795 Nov. 21 at 8:56 PM

$TGTX Someone just bought 200 Jan $40 calls.

2 · Reply

jmartin795 Nov. 21 at 8:10 PM

$TGTX This would be more impressive if we had some volume

2 · Reply

calbucs Nov. 21 at 8:06 PM

$TGTX There is my $32 ! , just a matter of time before this breaks out and we get a few weeks of nothing but positive Day after day increases . Looking at $40 plus by End of year .

1 · Reply

Market Cap	5.07B
Revenue (ttm)	329.00M
Net Income (ttm)	23.38M
EPS (ttm)	N/A
PE Ratio	10.95
Forward PE	10.55
Profit Margin	7.11%
Debt to Equity Ratio	0.40

Volume	2,686,000
Avg Vol	1,926,092
Day's Range	N/A - N/A
Shares Out	158.76M
Stochastic %K	93%
Beta	1.95
Analysts	Strong Sell
Price Target	$44.28